Ac-YVAD-pNA

CAS No. 149231-66-3

Ac-YVAD-pNA( ——— )

Catalog No. M41645 CAS No. 149231-66-3

Ac-YVAD-pNA is a specific Caspase-1 substrate. Ac-YVAD-pNA can be used to detect Caspase-1 activity. Caspase-1 is a key mediator of inflammatory processes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 114 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Ac-YVAD-pNA
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-YVAD-pNA is a specific Caspase-1 substrate. Ac-YVAD-pNA can be used to detect Caspase-1 activity. Caspase-1 is a key mediator of inflammatory processes.
  • Description
    Ac-YVAD-pNA is a specific Caspase-1 substrate. Ac-YVAD-pNA can be used to detect Caspase-1 activity. Caspase-1 is a key mediator of inflammatory processes.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Caspase-1
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    149231-66-3
  • Formula Weight
    628.639
  • Molecular Formula
    C29H36N6O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 250 mg/mL (397.69 mM; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pereira NA, et al. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity. Biochem Biophys Res Commun. 2008 Dec 19;377(3):873-7. ?
molnova catalog
related products
  • HBC514

    HBC514, a nonfluorescent HBC-analog, emits strong green fluorescence upon forming a tight complex with Pepper RNA aptamer.

  • Atezolizumab

    Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.

  • Rosabulin

    v Rosabulin (STA 5312) is an orally active microtubule inhibitor with potency. Rosabulin inhibits microtubule assembly and has broad-spectrum antitumor activity.